ldn
CLINICAL REFERENCE NOTE Low-Dose Naltrexone (LDN) in Solid Organ Transplant Recipients on Chronic Immunosuppression Prepared by Yoon Hang Kim, MD, MPH | Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Reviewed: May 2026 | Internal clinical reference — not patient-facing Bottom line The concern is pharmacodynamic and entirely theoretical.
The Warburg Effect: A Century-Old Discovery That Still Shapes How We Think About Cancer Yoon Hang Kim MD MPH Board Certified, Preventive Medicine Practice of Yoon Hang Kim MD | www.directintegrativecare.com In 1924, a German biochemist named Otto Warburg made an observation about cancer cells that puzzled his
MCAS
Mast Cell Activation Syndrome (MCAS): A New Epidemic The Common Node of Long COVID, Lyme Disease, Mold Toxicity, and the Modern Chronic Illness Crisis Yoon Hang Kim, MD, MPH | Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Direct Integrative Care | Membership-Based Integrative Telemedicine | May 2026 ⚠ MEDICAL DISCLAIMER
ldn
by Yoon Hang Kim MD Question: Can prednisone or other medications sometimes trigger a return of inflammatory pain symptoms in people who had previously been doing well on low-dose naltrexone (LDN)? For example, if someone had several months of significant pain relief on LDN, then developed an infection and
ldn
Q: I'm trying to determine if the joint pain I am having can be from the LDN. I'm currently at 3 mg and my feet and thumbs have been hurting more and more. Thinking back I'm beginning to think it started increasing when I
McCullough Protocol
An evidence-aware academic review of the “base spike detoxification” regimen of nattokinase, bromelain, and curcumin Yoon Hang Kim, MD, MPH | Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician www.directintegrativecare.com Medical Disclaimer This article is for educational purposes only and does not constitute medical advice, diagnosis,
ldn
Low-Dose Naltrexone and Gastrointestinal Health Mechanisms, Clinical Evidence, and Integrative Applications Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine Integrative & Functional Medicine Physician Abstract Low-dose naltrexone (LDN), administered at doses of approximately 0.5 to 4.5 mg daily, has emerged as a versatile off-
An Academic Book Chapter Yoon Hang "John" Kim, MD, MPH, FAAMA Practice of Yoon Hang Kim, MD San Antonio, TX www.directintegrativecare.com Serving MO May 2026 Copyright and Disclosures © 2026 by the author. This chapter is intended for academic and educational use. The material may be reproduced
ldn
Start-Low-Go-Slow Protocols for MCAS, ME/CFS, and Autoimmune Disease Yoon Hang “John” Kim, MD, MPH, FAAMA Board-Certified Preventive Medicine | Integrative & Functional Medicine | LDN Research Trust Presenter The short version If you’ve been told LDN will make you better but every dose so far has
cancer
Integrative Oncology A Comprehensive Academic Synthesis of Mechanisms, Guidelines, Evidence, and Clinical Translation (2022–2026) An Academic Book Chapter Yoon Hang "John" Kim, MD, MPH, FAAMA Practice of Yoon Hang Kim, MD www.directintegrativecare.com San Antonio, Texas May 2026 Copyright and Disclosures © 2026 by the author. This
Pentosan Polysulfate Sodium and Oral Absorption: What Patients and Clinicians Need to Know Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician www.directintegrativecare.com MEDICAL DISCLAIMER This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. The
mold
Food Source vs. Water Source Mold: A Clinically Actionable Framework for Mold-Illness Management Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Direct Integrative Care Abstract Mold-related illness—encompassing Chronic Inflammatory Response Syndrome (CIRS), mast cell activation syndrome (MCAS) triggered by biotoxins,